Recent publications
- “A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer” Hernando-Calvo A et al. Clin Colorectal Cancer. 2024 https://pubmed.ncbi.nlm.nih.gov/38960798/
- “Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.” Chapman JW et al. J Clin Oncol. 2024 https://pubmed.ncbi.nlm.nih.gov/38824432/
- “Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM Trial” Bartlett JMS et al. Clin Cancer Res. 2024 https://pubmed.ncbi.nlm.nih.gov/38345755/
- “Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions” Purdue MP, Dutta D, Machiela MJ, Gorman BR et al. Nat Genet. 2024 https://pubmed.ncbi.nlm.nih.gov/38671320/
- “Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance” Berman DM et al. J Urol. 2023 https://pubmed.ncbi.nlm.nih.gov/37126232/
- “Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study” Acs B et al. Mod Pathol. 2022 https://pubmed.ncbi.nlm.nih.gov/35729220/
- “Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer” Xu K et al. J Mol Diagn. 2022 https://pubmed.ncbi.nlm.nih.gov/35526835/
- “Evaluation of multiple transcriptomic gene risk signatures in male breast cancer” Bayani J, Poncet C et al. NPJ Breast Cancer 2021 https://pubmed.ncbi.nlm.nih.gov/34312396/
- “Multisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumours” Bartlett J et al. PLoS One. 2021 https://pubmed.ncbi.nlm.nih.gov/34597339/
- “Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study” Bartlett JMS, Bayani J, Kornega E et al. NPJ Breast Cancer 2021 https://pubmed.ncbi.nlm.nih.gov/34238931/
- “Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer” Chong T et al. J Ovarian Res 2018 https://pubmed.ncbi.nlm.nih.gov/29618387/